Abiopharma

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001437749-25-027145 Size: 13 KB

New Form 144 - COHERENT CORP. Filed: 2025-08-15 AccNo: 0001950047-25-005923 Size: 6 KB

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001437749-25-027144 Size: 10 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0000950170-25-109408 Size: 5 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0000950170-25-109409 Size: 7 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0000950170-25-109410 Size: 5 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0000950170-25-109411 Size: 5 KB

New Form 144 - Harmony Biosciences Holdings, Inc. Filed: 2025-08-15 AccNo: 0001950047-25-005919 Size: 4 KB

New Form SCHEDULE 13G - Y-mAbs Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001076809-25-000098 Size: 8 KB

New Form 144 - ANI PHARMACEUTICALS INC Filed: 2025-08-15 AccNo: 0001950047-25-005913 Size: 4 KB

New Form 144 - Avidity Biosciences, Inc. Filed: 2025-08-15 AccNo: 0001950047-25-005911 Size: 5 KB

New Form 144 - QIAGEN N.V. Filed: 2025-08-15 AccNo: 0001950047-25-005910 Size: 8 KB

New Form 144 - ANI PHARMACEUTICALS INC Filed: 2025-08-15 AccNo: 0001950047-25-005908 Size: 5 KB